CD19 and cancer: Third, it is not clear whether the entry of anti-CD19 CAR T cells into non-draining lymph nodes was influenced by cancer cells or whether the altered chemokine receptor profile of antigen-activated anti-CD19 CAR T cells facilitated their entry.